Video | Business Headlines | Internet | Science | Scientific Ethics | Technology | Search

 

Benefit for NZ in Demand for Clone-Free Food


Economic Benefit for New Zealand In Meeting Demand for Clone-Free Food

New Zealand's food exports to the world could get a boost by meeting the demand for clean, natural, and safe "clone-free" food.

Despite consumer resistance, demands for testing and labelling, and calls by Congress for more research, US authorities have approved for sale food products derived from cloned animals.

"Many US consumers will look for sources of natural, clone-free foods. As clones penetrate the US industry manufacturers worldwide will seek out alternative supplies and New Zealand producers should be high on the list," says Jon Carapiet from GE Free NZ in food and environment.

The issue of cloned animals has yet to be debated in New Zealand, but marketing realities mean that even if some people in the agricultural sector want to use cloned animals, they risk sabotaging our international brand reputation on which our economy relies.

To ensure consumer confidence in New Zealand products worldwide, New Zealand producers should maintain a GE-free and Clone-free policy.

This needs to be backed up by traceability "from farm to fork", and labelling of products to ensure they are clearly marketed as clone-free and in line with our Brand reputation as clean, green and natural New Zealand.

ENDS


REFERENCES: FDA Approves Food from Clones against the Will of Congress and the American Public

www.centerforfoodsafety.org

Despite scant data, congressional action demanding further research and over 150,000 public comments in opposition, FDA approved the sale of meat and milk from cloned animals yesterday. In addition, the FDA will not require any special procedures for tracking or handling food products from clones. It will not require labeling of any kind on food products from clones or their offspring, depriving consumers of their right to know about the origins of their food. This action comes at a time when Congress has voted twice to delay FDA’s decision on cloned animals until additional safety and economic studies can be completed.

The FDA’s bullheaded action disregards the will of the public and Congress. FDA based their decision on an incomplete and flawed review that relies on studies supplied by cloning companies that want to force cloning technology on American consumers. FDA’s action has placed the interests of a handful of biotech firms above those of the public they are charged with protecting.

While FDA may deem these products safe to enter the market, companies like Ben & Jerry’s and Organic Valley have pledged not to use cloned animals or their offspring. Dean Foods, Hormel, Tyson and Smithfield Foods have also stated they do not plan to accept milk or meat from cloned animals, but have not addressed their plans regarding the offspring of clones.


© Scoop Media

 
 
 
 
 
Business Headlines | Sci-Tech Headlines

 

Back Again: Government Approves TPP11 Mandate

Trade Minister Todd McClay says New Zealand will be pushing for the minimal number of changes possible to the original TPP agreement, something that the remaining TPP11 countries have agreed on. More>>

ALSO:

By May 2018: Wider, Earlier Microbead Ban

The sale and manufacture of wash-off products containing plastic microbeads will be banned in New Zealand earlier than previously expected, Associate Environment Minister Scott Simpson announced today. More>>

ALSO:

Snail-ier Mail: NZ Post To Ditch FastPost

New Zealand Post customers will see a change to how they can send priority mail from 1 January 2018. The FastPost service will no longer be available from this date. More>>

ALSO:

Property Institute: English Backs Of Debt To Income Plan

Property Institute of New Zealand Chief Executive Ashley Church is applauding today’s decision, by Prime Minister Bill English, to take Debt-to-income ratios off the table as a tool available to the Reserve Bank. More>>

ALSO:

Divesting: NZ Super Fund Shifts Passive Equities To Low-Carbon

The NZ$35 billion NZ Super Fund’s NZ$14 billion global passive equity portfolio, 40% of the overall Fund, is now low-carbon, the Guardians of New Zealand Superannuation announced today. More>>

ALSO: